Reviewed by Michael Gill, B. Sc.
24 Inflammatory Breast Cancer Clinical Trials Near Me
Top Hospitals for Inflammatory Breast Cancer Clinical Trials
Image of M D Anderson Cancer Center in Texas.
M D Anderson Cancer Center
Houston
12Active Trials
16All Time Trials for Inflammatory Breast Cancer
2007First Inflammatory Breast Cancer Trial
Image of Dana-Farber Cancer Institute in Massachusetts.
Dana-Farber Cancer Institute
Boston
5Active Trials
5All Time Trials for Inflammatory Breast Cancer
2016First Inflammatory Breast Cancer Trial
Top Cities for Inflammatory Breast Cancer Clinical Trials
Most Recent Inflammatory Breast Cancer Clinical Trials
Top Treatments for Inflammatory Breast Cancer Clinical Trials
Treatment Name
Active Inflammatory Breast Cancer Clinical Trials
All Time Trials for Inflammatory Breast Cancer
First Recorded Inflammatory Breast Cancer Trial
Pembrolizumab
3
4
2015
Neratinib
2
2
2018
Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)
1
1
2022
Dasatinib
1
1
2022
Eribulin Mesylate
1
1
2021
Recently Completed Studies with FDA Approved Treatments for Inflammatory Breast Cancer
Treatment
Year
Sponsor
Nab-paclitaxel
2010
M.D. Anderson Cancer Center

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: November 18th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Klichinsky M, Ruella M, Shestova O, Lu XM, Best A, Zeeman M, Schmierer M, Gabrusiewicz K, Anderson NR, Petty NE, Cummins KD, Shen F, Shan X, Veliz K, Blouch K, Yashiro-Ohtani Y, Kenderian SS, Kim MY, O'Connor RS, Wallace SR, Kozlowski MS, Marchione DM, Shestov M, Garcia BA, June CH, Gill S. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020 Aug;38(8):947-953. doi: 10.1038/s41587-020-0462-y. Epub 2020 Mar 23. https://pubmed.ncbi.nlm.nih.gov/323617132 Michmerhuizen AR, Pesch AM, Moubadder L, Chandler BC, Wilder-Romans K, Cameron M, Olsen E, Thomas DG, Zhang A, Hirsh N, Ritter CL, Liu M, Nyati S, Pierce LJ, Jagsi R, Speers C. PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation. Mol Cancer Ther. 2019 Nov;18(11):2063-2073. doi: 10.1158/1535-7163.MCT-19-0520. Epub 2019 Aug 14. https://pubmed.ncbi.nlm.nih.gov/31413177